CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 22, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a global strategic...
Hence then, the article about harbour biomed enters global strategic collaboration with otsuka to advance bcmaxcd3 bispecific t cell engagers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers )
Also on site :
- The Iran War Hits Your Pocket
- Fall 2026 TV: The Ultimate Return Guide for Every Cop, Medical and Legal Drama
- Two teenagers killed in Shiraz, two dead in Abu Dhabi as Iran war expands